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University of Missouri-Columbia, Columbia, MissouriABSTRACT Previous cysteine scanning studies of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride
channel have identified several transmembrane segments (TMs), including TM1, 3, 6, 9, and 12, as structural components of the
pore. Some of these TMs such as TM6 and 12 may also be involved in gating conformational changes. However, recent results
on TM1 seem puzzling in that the observed reactive pattern was quite different from those seen with TM6 and 12. In addition,
whether TM1 also plays a role in gating motions remains largely unknown. Here, we investigated CFTR’s TM1 by applying meth-
anethiosulfonate (MTS) reagents from both cytoplasmic and extracellular sides of the membrane. Our experiments identified
four positive positions, E92, K95, Q98, and L102, when the negatively charged MTSES was applied from the cytoplasmic
side. Intriguingly, these four residues reside in the extracellular half of TM1 in previously defined CFTR topology; we thus
extended our scanning to residues located extracellularly to L102. We found that cysteines introduced into positions 106,
107, and 109 indeed react with extracellularly applied MTS probes, but not to intracellularly applied reagents. Interestingly,
whole-cell A107C-CFTR currents were very sensitive to changes of bath pH as if the introduced cysteine assumes an altered
pKa-like T338C in TM6. These findings lead us to propose a revised topology for CFTR’s TM1 that spans at least from E92 to
Y109. Additionally, side-dependent modifications of these positions indicate a narrow region (L102-I106) that prevents MTS
reagents from penetrating the pore, a picture similar to what has been reported for TM6. Moreover, modifications of K95C,
Q98C, and L102C exhibit strong state dependency with negligible modification when the channel is closed, suggesting a signif-
icant rearrangement of TM1 during CFTR’s gating cycle. The structural implications of these findings are discussed in light of the
crystal structures of ABC transporters and homology models of CFTR.INTRODUCTIONCystic fibrosis transmembrane conductance regulator
(CFTR), an integral membrane protein whose dysfunction
causes the inherited disease cystic fibrosis (1), is a unique
member of the ABC transporter superfamily in that it serves
as an anion channel that allows chloride ions to move
passively across plasma membranes down their electro-
chemical gradient (1,2). Like many ABC exporters, CFTR
harbors two nucleotide-binding domains (NBDs) and two
transmembrane domains (TMDs), each of which comprises
six transmembrane segments. It has long been established
that CFTR, although belonging to the ABCC subfamily
(3), has several unique molecular properties. CFTR distin-
guishes itself from other ABC transporters; first, because
it possesses a regulatory domain (R domain) in which
several consensus serines can be phosphorylated by protein
kinase A (PKA). Phosphorylation of the R domain is a
prerequisite for ATP to gate the channel (4–6). Second,
although CFTR retains the conserved motion of dimeriza-
tion and partial separation of its NBDs for gating conforma-
tional changes (7–10), the structural rearrangements of its
TMDs must be somewhat different from those adopted by
ABC transporters because the classical flip-flop movementsSubmitted August 29, 2012, and accepted for publication December 31,
2012.
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0006-3495/13/02/0786/12 $2.00of the TMDs in ABC transporters (11) that shuffle the
conformation between inward-facing and outward-facing
configurations do not afford a contiguous aqueous pathway
for ion diffusion. Nevertheless, a recent report (12) provided
evidence supporting the degraded transporter hypothesis:
CFTR may employ similar conformational changes in its
TMDs during gating but its cytoplasmic gate is degenerated
(see (12) for details, but cf. (13)).
More than two decades since the CFTR gene was cloned
(1), numerous structural and functional studies have
amassed tremendous knowledge with respect to the gating
and permeation mechanisms of CFTR (reviewed in (14)).
Among many issues of interest, identifying the structural
components for the anion permeation pathway is especially
interesting in light of the apparent evolutionary relationship
between CFTR, an ion channel, and ABC exporters carrying
out the function of active transport. Based on hydropathy
analysis, 12 transmembrane segments (TMs) were assigned
to CFTR’s TMDs (Fig. 1 A, (1)). Substituted cysteine acces-
sibility methods (SCAM) have been employed in examining
targeted transmembrane segments in numerous transporters
and channels (12,15–21). For CFTR, this technique has also
been fruitful in recent years in identifying several pore-
lining segments (12,16,18,22–25), some of which are inti-
mately involved in gating motion (12,16,18,22,26). Finally,
crystal structures of four ABC exporters, namely Sav1866
(27,28), MsbA (29), mouse P-glycoprotein (30), andhttp://dx.doi.org/10.1016/j.bpj.2012.12.048
FIGURE 1 Traditional topology of CFTR and
effects of MTSES on cysteine-substituted CFTR
mutant channels. (A) Topological map of CFTR
based on hydropathy analysis shows the domain
structure of CFTR: two TMDs, two NBDs, and
an R domain. The first transmembrane segment
(TM1) is colored black with its amino acid
sequence shown above. Eight residues previously
assigned as the first extracellular Loop (ECL1)
were labeled in gray. The innermost and outermost
residues of TM6 and TM12 were also marked.
(B) Cytoplasmic application of MTSES dramati-
cally reduced ATP-gated L102C/Cysless channel
currents in an excised inside-out membrane patch.
(C) Macroscopic current trace showing a lack of
effect of MTSES on F87C/Cysless channels.
Roles of TM1 in CFTR Function 787TM287/288 (31), have been solved. Although the field is
still waiting for the high-resolution structure of CFTR,
these crystal structures of ABC exporters do provide the
framework for building homology models that could poten-
tially shed some light on the structural attributes of CFTR
(15,32–34). Furthermore, although bearing some defi-
ciencies (see Discussion for details), these models indeed
provide a handful of predictions that have been verified by
functional studies (12,16,18,22).
A general picture emerges from our previous SCAM
studies on TM6 and 12: there is an accessibility limit in
the middle of these two TMs when thiol-reactive, channel
impermeant probes were applied from the cytoplasmic
side of the membrane (12,16). Together with data from
whole-cell experiments where the engineered cysteines
were probed from the extracellular end, Alexander et al.
(15) and Norimatsu et al. (23) proposed a bottleneck region
in the pore that is composed of amino acids 338–341 in TM6
and 1131–1140 in TM12. By contrast, recent data on TM1
(35), depict a very different picture as this barrier to channel
impermeant thiol-reagents seems located close to the extra-
cellular end of this TM defined originally in Riordan et al.
(1). This puzzling observation raises at least two possibili-
ties. First, TM1 may not line the pore and the reported
macroscopic current response to methanethiosulfonate
(MTS) reagents is a result of effects on gating. Second,
the assigned topology of TM1 (1) may not be accurate so
that the pore-lining segment of TM1 actually extends into
the first extracellular loop. To resolve this issue, we decided
to carry out more extensive SCAM studies on TM1.
In the current study, SCAM experiments were performed
with both inside-out membrane patches, to which MTS
probes were applied from the cytoplasmic side, andwhole-cell recordings, which allow testing reactivity with
extracellular-applied MTS reagents. Overall, seven reactive
sites (E92, K95, Q98, L102, I106, A107, Y109) were iden-
tified. The periodicity of these positive hits suggests that
TM1, like the internal part of TM6 and TM12 (12,16),
also assumes an a-helical structure. More importantly, the
reactivity patterns toward intracellularly and extracellularly
applied MTS probes indeed suggest a 4-amino-acid bottle-
neck (102–106) similar to what has been reported for
TM6 (15,16,23). However, as positions 103–109 were clas-
sified as the first extracellular loop in the traditional topolog-
ical map of CFTR’s TMDs (1), our findings suggest
a different membrane-spanning topology for TM1: instead
of being part of a disordered extracellular loop, we propose
that amino acids 103–109 constitute part of a more struc-
tured ion permeation pathway. Another unique feature of
TM1 is the observation that modifications of engineered
cysteines at positions 95, 98, and 102 are strictly state
dependent—modifications occur nearly exclusively in the
open state. Structural implications of this finding will be
discussed.MATERIALS AND METHODS
Channel expression
To avoid effects of MTS reagents on endogenous cysteines in CFTR,
a construct with all endogenous cysteines altered (i.e., cysless background)
was used. All mutations were confirmed with DNA sequence (DNA Core,
University of Missouri). Chinese hamster ovary cells grown at 37 in Dul-
becco’s modified Eagle’s medium plus 10% fetal bovine serum were used to
express the channels. The pcDNA of all mutants were transfected into cells
together with pEGFP-C3 (Takara Bio), which encodes green fluorescent
protein, using PolyFect reagent (QIAGEN, Venlo, Netherlands) accordingBiophysical Journal 104(4) 786–797
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35 mm tissue culture dishes and incubated under 27 for 2–7 days before
experiments were performed.Electrophysiology
Inside-out mode
Glass electrodes were prepared with a two-stage vertical puller (Narishige,
Tokyo, Japan), and polished with a homemade microforge to yield a resis-
tance between 2 and 5 MU when placed in the bath solutions containing (in
mM): 145 NaCl, 5 KCl, 2 MgCl2, 1 CaCl2, 5 glucose, 5 HEPES, 20 sucrose,
with pH adjusted to 7.4 using NaOH. After the patch was excised into an
inside-out configuration, the perfusion solution was changed to one con-
taining (in mM): 150 NMDG-Cl, 10 EGTA, 10 HEPES, 8 Tris, 2 MgCl2,
with pH adjusted to 7.4 using NMDG. The pipette solution contained
140 NMDG-Cl, 2 MgCl2, 5 CaCl2, 10 HEPES, with pH adjusted to 7.4
using NMDG. To achieve fast solution changes, the pipette tip was moved
to the outlets of a three-barrel glass tubing under the control of a fast solu-
tion exchange system (SF-77B; Warner Instruments, Hamden, CT). The
current signal was recorded with a patch clamp amplifier (EPC10;
HEKA), filtered at 100 Hz with a Bessel filter and digitized at 500 Hz using
Pulse (V8.80; HEKA). All the experiments were performed at room
temperature.
Whole-cell mode
Pipettes used in whole-cell experiments were made with the same puller
described previously, but not polished to yield a resistance of ~1.5–2.5
MU when filled with whole-cell pipette solution containing (in mM):
10 EGTA, 10 HEPES, 20 TEACl, 10 MgATP, 2 MgCl2, 85 aspartate,
16 pyruvate, 5.8 glucose, with pH adjusted to 7.4 using CsOH. Bath
solutions of various pH values were adjusted with H2SO4 and cacodylic
acid, respectively. A voltage ramp of 5100 mV over 200 ms was applied
every 5 s. The current was acquired with a patch clamp amplifier
(EPC10; HEKA), filtered at 1 kHz and digitized at 2 kHz with Pulse
software (V8.80; HEKA). Experiments were also conducted at room
temperature.Reagents and chemical modification
MTS reagents (Toronto Research Chemicals, Toronto, Ontario, Canada)
were stored at 70 as 100 mM stock solutions. Each aliquot was diluted
into 1 mM (inside-out) or 0.5 mM (whole-cell) immediately before appli-
cation. Due to possible spontaneous oxidation of the introduced cysteines
(36,37), dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO) was added
into the cocktail containing PKA and ATP to ensure that the engineered
cysteines are mostly in the reduced form before applications of the MTS
reagents. CFTRinh-172 was kindly provided by Dr. Robert Bridges with
support from the Cystic Fibrosis Foundation Therapeutics. ATP and PKA
were bought from Sigma-Aldrich.Data analysis
To calculate the modification rate by MTS reagents, we first fitted the
current decay phase in each recording with a single exponential function
with the Igor program (V4.07; WaveMetrics, Portland, OR) to obtain the
time constant, t. The modification rate constant was computed as 1/(t*
[MTSES]) where [MTSES] is the concentration of MTSES. Single-channel
kinetics analysis was conducted using the program developed by L. Csa-
na´dy (2000) (38), where C-O-B mode was chosen to extract the kinetics
parameters. Student’s paired and equal variance t-test (two-tailed) was con-
ducted with Excel (Microsoft). P< 0.05 was considered significant. Data in
the text were presented as means 5 SE. n represents the number of data
points for each experiment.Biophysical Journal 104(4) 786–797RESULTS
Cysteine scanning of TM1 using both internal and
external thiol-specific probes
To investigate the role of TM1 in CFTR’s pore-forming
constituents, individual cysteines were introduced into
each position (81–102) along previously assigned TM1 (1)
under the cysless background as described before (12,16).
After the channels were expressed in the cell membrane,
inside-out patches containing cysteine-substituted channels
were made to test their reactivity toward 2-sulfonatoethyl
MTS reagents. In all the inside-out recordings, a cocktail
containing PKA and ATP was first used to maximally acti-
vate the channels. Subsequently, chloride currents were
induced by ATP to a steady-state level before the channels
were exposed to intracellularly applied MTS reagents in
the continuous presence of ATP for at least 1 min or until
the current reaches a steady level. We then switched the
perfusion solution back to one with ATP alone to ensure
that any reactivity is not reversed by removal of the reagent.
Fig. 1 B shows a representative recording of L102C mutant
channels in response to the application of MTSES. This
observed decrease of macroscopic currents is due to cova-
lent modification of the engineered cysteines by the reagent
as the effect persisted even after a complete removal of
MTSES. Similar observations were made for K95C- and
Q98C-CFTR. We could only obtain microscopic current
with E92C-CFTR probably due to a poor expression, but
the application of MTSES decreased the single-channel
amplitude of this construct (see below). Strikingly, cysteines
placed in all other 18 positions did not respond to MTSES.
For instance, in the case of the F87C mutant channel, no
obvious changes in the mean current were seen during
a 1-min application of MTSES (Fig. 1 C). However, one
cannot rule out the possibility that these channels were
modified but without apparent changes in gating or
permeation.
Fig. 2 summarizes our results described previously. Data
on TM6 and 12 from our previous reports (12,16) are pre-
sented for comparison. Two differences were noted. First,
fewer positions show positive response to MTSES (4 in
TM1 vs. 6 in TM6 and 8 in TM12). Nonetheless, the
apparent periodicity with the four reactive positions on
TM1 is consistent with the notion that this part (E92 to
L102) of TM1 assumes a secondary structure of an a-helix,
just like the intracellular half of TM6 and TM12 (12,16).
Second, most surprisingly, unlike TM6 and TM12, all four
reactive positions on TM1 reside in the extracellular half
of this segment according to the traditional topology built
on hydropathy analysis (Figs. 1 A and 2). Thus, although
the accessibility limits for TM6 (position 341) and TM12
(position 1140) are located approximately in the middle of
these TMs, L102 is the outermost residue in the classical
topological map of TM1 (1). We therefore extended our
cysteine scanning of TM1 to residues beyond the L102
FIGURE 2 Summary of SCAM results on TM1
(middle), TM6, and TM12 (left and right). The
inhibition ratio was calculated as (1-Ia/Ib), where
Ia and Ib are mean currents after and before appli-
cation of MTSES, respectively. Those positions
colored in gray in the middle panel (TM1) repre-
sent residues on ECL1 in the traditional topolog-
ical map (Fig. 1 A). Stars marked above positions
85 and 103 indicate no current was detected from
these two mutants, whereas the dagger (y) on posi-
tion 92 specifies that the measurement was from
changes of the single-channel current amplitude
by MTSES due to a low expression level. The
dotted line delineates the extracellular end of
each segment in the traditional CFTR topology.
Data were extracted from 2 to 8 patches for each
mutant. Results on TM6 and TM12 were obtained
from Bai et al. (12,16).
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Although we failed to detect any currents from G103C-
CFTR, all other seven cysteine-substituted constructs did
not respond to cytoplasmic application of MTSES to
a significant extent (Fig. 2). We conclude that the accessi-
bility limit to intracellular MTSES is indeed at position
102 as reported by Wang et al. (35).
If TM1 indeed constitutes part of the pore-forming
domain, the different location of the accessibility limit
described previously between TM1 and TM6 raises an inter-
esting possibility that the traditional topological map for
TM1 may not be correct. In other words, some of the resi-
dues external to L102 may actually reside in the pore. To
test this hypothesis, we performed whole-cell experiments
in which MTS reagents could be applied from the extracel-
lular side. Replacing each residue from 103 to 110 with
cysteine results in robust cAMP-dependent whole-cell
currents with the exception of position 103, where no detect-
able currents were observed, probably due to poor expres-
sion. Fig. 3 A shows a continuous whole-cell recording of
I106C-CFTR currents. Whole-cell CFTR currents were first
activated with 10 mM forskolin. Once the current reached
a steady state, application of 0.5 mM MTSES nearly abol-
ished the current completely. This inhibition is irreversible
because washout of MTSES did not recover the current.
Further addition of a specific CFTR inhibitor, CFTRinh-
172 (39,40), caused a minor decrease of the residual current,
indicating a drastic reduction of I106C-CFTR currents by
external MTSES. Similar results were obtained for
A107C- and Y109C-CFTR except that the magnitude ofinhibition for A107C-CFTR is significantly smaller (Fig. 3
C). In contrast, minimal effects of external MTSES were
seen with the other four positions (R104, I105, S108, and
D110). Fig. 3 B shows an example of these negative
responders. We next tested the accessibility to external
MTSES on three positions identified by experiments with
inside-out patches, namely K95C, Q98C, and L102C, in
the same manner and all three positions turned out nonreac-
tive (data not shown).
Two tentative conclusions can be made based on the
results shown so far. First, when we consider all seven posi-
tive hits spanning the segment from E92 to Y109, a period-
icity consistent with a secondary structure of an a-helix
emerges. Second, the observation that L102 constitutes the
internal accessibility limit while I106 acts as an external
accessibility limit, indicates a 4-amino-acid bottleneck
that prevents 6 A˚ MTSES from penetrating the pore from
either side of the membrane. This latter conclusion bears
remarkable resemblance to what has been shown for TM6
(T338–S341 (16,23)).
The similarity between TM1 and TM6 was reinforced by
the following results with A107C mutant channels. When
recording whole-cell A107C-CFTR current with a chloride
gradient (24 mM internal and 156 mM external [Cl]), we
found that instead of an expected outward rectified I-V
curve due to this imposed concentration gradient, the
observed I-V relationship shows significant inward rectifica-
tion (Fig. 4 A). Furthermore, the degree of inhibition by
MTSES under 80 mV (54.9 5 1.4%, n ¼ 4) was signifi-
cantly higher than that underþ80 mV (41.65 3.7%, n¼ 4)Biophysical Journal 104(4) 786–797
FIGURE 3 SCAM experiments with whole-cell
recordings. (A) A continuous recording of whole-
cell I106C/Cysless channel current in response to
an external application of MTSES. The I-V rela-
tionships for net CFTR currents before (b-a) and
after (c-a) MTSES modification were shown below
the trace. (B) The same protocol was adopted for
S108C/Cysless mutant channels, which exhibit
little response to external MTSES. However,
reversible inhibition by CFTRinh-172 shows that
the current observed was indeed due to the activa-
tion of CFTR. (C) Summary of whole-cell SCAM
results on the eight residues, G103C-D110C. Data
at580 mV were presented to illustrate the unique
voltage-dependent inhibition by MTSES at posi-
tion 107. The number of cells was labeled at the
end of each bar. * indicates no detectable current
for G103C-CFTR.
790 Gao et al.for this mutant (Figs. 3 C and 4 A). These observations can
be explained if the introduced cysteine at position 107 has
a pKa that is lower than that of cysteine in the bulk solutionFIGURE 4 Effects of external MTSES and pH on A107C-CFTR. (A)
Whole-cell A107C-CFTR currents in response to external MTSES (left)
and I-V curves extracted from the whole-cell recording as marked. (B)
Effects of acidic or alkaline pH on the whole-cell A107C-CFTR currents
(left). Corresponding I-V relationships were shown on the right. (C) A
control experiment on WT/Cysless demonstrating a lack of effect by
changes of bath pH.
Biophysical Journal 104(4) 786–797(between 8.10 and 8.72 (41)). At pH 7.4, C107 can then be
considered to carry a partial negative charge, a scenario
analogous to placing a cysteine at position 338 in TM6
(42). We next adopted the similar strategy used in Liu
et al. (42) to test if A107C-CFTR can be modulated with
baths of different pH. In Fig. 4 B, A107C-CFTR channel
currents were first activated with forskolin in the bath solu-
tion with a pH of 7.4; after the current level stabilized, the
bath was switched to forskolin-containing solution with
a pH of 6 or 8. As shown in Fig. 4 B, whole-cell currents
atþ80 mV increase by 182.75 9% (n¼ 4) as the bath solu-
tion is acidified, but decrease by 44.85 3.2% (n ¼ 4) upon
lowering bath [Hþ]. Switching among bath solutions with
different pH allows us to determine the pKa value of the
cysteine engineered at position 107. As shown in Fig. S1
in the Supporting Material, the pKa value of C107 is 7.25,
which is nearly identical to that of T338C in TM6 (42).
These results are consistent with the idea that the side chain
of the introduced cysteine at position 107 is partially depro-
tonated resulting in a negatively charged thiol group (-S)
that impedes chloride permeation. An increase of the bath
[Hþ] then neutralizes this -S. As a control, neither pH 6
nor pH 8 bath alters whole-cell cysless channel currents
significantly (Fig. 4 C). These results further support the
idea that the side chain of residue 107 lines the pore.Modifications by MTS-ethyltrimethylammonium
(MTSET) affect gating and permeation
One interesting feature about SCAM studies on TM6 is the
dual effects of MTSET modification on CFTR gating and
permeation (16). Similar but not identical observations
Roles of TM1 in CFTR Function 791were made with TM1. For instance, for L102C mutant chan-
nels, we found that macroscopic currents were increased by
108.55 9.5% (n¼ 6) after modification by MTSETapplied
to the cytoplasmic side of the channel in excised inside-out
patches (Fig. 5 A). Also similar to what has been reported
for positions I344 and M348 in TM6, following MTSET
modification of L102C-CFTR, robust activity was observed
even in the complete absence of ATP. This dramatic effect
on CFTR gating was readily reversed by the reducing
reagent DTT. For Q98C and K95C mutant channels, the
increases in the mean current amplitude following MTSET
modification were ~2- and 6-fold, respectively. Because the
single-channel conductance was drastically decreased in
K95C-CFTR, we were not able to assess the gating effect
of MTSET modification. Fig. S2, however, shows that
MTSET modification of Q98C-CFTR increases both the
open probability and the single-channel amplitude.
The remarkable effects of MTSET on L102C-CFTR
currents shown in Fig. 5 A prompted us to examine this
effect more closely with single-channel recordings. Fig. 5 B
shows single-channel traces before and after MTSET modi-FIGURE 5 Gating of MTSET-modified L102C/Cysless channel. (A) A
continuous current recording of L102C/Cysless channels showing that
MTSET modification increases the macroscopic current and renders the
current ATP-independent. (B) Single-channel recording of the L102C/
Cysless-CFTR. Note the unusually numerous flickery closings in each
opening burst before MTSET modification (compare Fig. 7 A, below).
The single-channel amplitude was decreased by MTSET modification,
but the Po was increased to near unity. The reducing reagent, DTT, effec-
tively reversed the effect of MTSET modification.fication of L102C-CFTR. Several intriguing findings were
made. First, before MTSET modification, each opening
burst was interrupted by many flickery closings (compare
Fig. 7 A below). Although previous studies have provided
evidence that these short-lived closures are ATP indepen-
dent (43,44) and could result from voltage-dependent block
of the pore by large anions from the cytoplasmic side of the
channel (45), it is noted that these events are abundantly
present in the double mutant L102C/E1371Q at both nega-
tive and positive membrane potentials in the absence of
ATP (see Fig. S3). If we accept the premise that the NBDs
of this hydrolysis-deficient channel remained in a dimeric
configuration throughout the recording, these transitions
could then represent autonomous opening and closing of
the gate while the NBDs are dimerized. Thus, the L-to-C
mutation at position 102 somehow destabilizes the gate of
the channel. Second, after modification by MTSET, the
single-channel current amplitude decreases by 46.4 5
1.3% (n ¼ 4), but the Po increases dramatically (Fig. 5 B).
In fact, the modified channel remains nearly always open
even after removal of ATP. Similar to what we observed
for I344C- and M348C-CFTR (16), this robust ATP-inde-
pendent gating was seen following modification by MTSET
but not by MTS-ethylammonium (MTSEA) (Fig. S4).State-dependent modification of E92C-, K95C-,
Q98C-, and L102C-CFTR
The observation that MTSET modification of Q98C and
L102C alters CFTR gating suggests that TM1 indeed partic-
ipates in gating motions of CFTR. However, because only
one position in each helical turn of the segment from E92
to L102 reacts with MTS reagents, it seems hard to envision
that similar rotational movements proposed for TM6 and 12
can be applied to TM1. To better understand the molecular
motion TM1 may undergo during gating transitions, we
adopted the protocol originally designed by Yellen’s group
(46) and lately applied to SCAM studies of CFTR (12). In
these experiments, channels were first activated by PKA
plus ATP; after ATP washout, two brief pulse applications
of ATP were implemented to ensure a stationary recording
condition is fulfilled. Subsequently, we applied ATP for
3 s until the current reached a steady state, followed by an
8-s washout phase to allow channel closure; MTSES was
then applied for 3 s in the absence of ATP followed by
a 2-s washout of MTSES. The same cycle would be repeated
12 times. As this series of experiments requires macroscopic
currents, we could not test the E92C mutants, which express
poorly (see Discussion for details). However, Fig. 6 A shows
a representative recording of current response for K95C-
CFTR mutants. Strikingly, the macroscopic current ampli-
tude remains fairly constant over a recording time longer
than 3 min. Similar results were obtained from experiments
on L102C (Fig. 6 B) and Q98C mutants. These data suggest
that the modification rate of cysteines on these positions isBiophysical Journal 104(4) 786–797
FIGURE 6 State-dependent modification by MTSES at positions 95, 98,
and 102. (A) A representative recording for MTSES modification in the
absence of ATP for K95C/Cysless channels. (B) A real-time recording
with a similar protocol shown in (A) for L102C/Cysless channels. Although
very little current was affected by application of MTSES in the absence of
ATP, exposure of the same patch to MTSES in the presence of ATP readily
diminished the current. (C) Summary of the modification rates for K95C,
Q98C, and L102C in the presence of ATP (solid squares). The modification
rates in the absence of ATP (crossed circles), were all set at 1 because the
modification, if at all, was too slow to be quantified accurately. n ¼ 5 for
each construct.
792 Gao et al.exceedingly low, if at all, when the channels are in the
closed state.
On the contrary, in the presence of ATP when the chan-
nels stay in the open state for a significant amount of
time, the introduced cysteine at all these positions can be
readily modified by MTSES (e.g., Fig. 1 B, Fig. 6 B). We
measured the modification rate in the presence of ATP by
fitting the current decay with a single exponential function
and the resulting time constant was converted to the second
order rate constant as described previously (12). Fig. 6 C
summarizes these results. Thus, these positions in TM1
are accessible to MTSES when channels are open but not
when they are closed, hinting at a gating-associated struc-
tural rearrangement of TM1 relative to other parts of CFTR.DISCUSSION
SCAM studies on CFTR’s TM1 in the current manuscript
are consistent with the hypothesis that portions of thisBiophysical Journal 104(4) 786–797segment could line the anion-conducting pore. The reac-
tivity of cysteines substituted in the presumed, pore-lining
region of TM1 toward internally applied, polar, thiol-
specific reagents is strikingly favored in the open state of
the channel. This result suggests that conformational
changes underlying channel closing can restrict the accessi-
bility of cysteines substituted in this region of TM1 to
reagents that enter the pore from the cytoplasmic side.
Furthermore, a direct comparison of the reactivity of cyste-
ines substituted into TM1 toward externally and internally
applied, thiol-directed reagents is consistent with previous
studies that identify a bottleneck in the pore that restricts
the permeation of MTS reagents and may be rate-limiting
for anion conduction (23).
With the completion of cysteine scanning on TM1, we
now have two TMs (1,6) thoroughly investigated with
channel impermeant probes applied from both the extracel-
lular and intracellular end of the CFTR pore (15,16,22,35).
Although some differences exist between these two sets of
data, they do share remarkable similarities. In the following
sections, we will not only elaborate the structure/function
implications of the data on TM1 in its own right, but also
discuss how these differences and similarities between
TM1 and TM6 may shed light on the evolutionary relation-
ship between CFTR and ABC exporters.
However, we need to first point out a few puzzling differ-
ences between current results and those published by others
(35). First, the four positions identified by cytoplasmic
application of MTSES are not exactly the same (E92,
K95, Q98, and L102 in the current study but K95, Q98,
P99, and L102 in (35)). Second, although we failed to detect
any reactivity to extracellular or intracellular application of
MTSES at position 104, Zhou et al. (47) reported that
a cysteine placed at this position does react with external
MTS reagents (see Fig. S5 for detail). Third, in the report
by Wang et al. (35), K95C, but not Q98C, P99C, or
L102C, can react with internal MTSES even before the
channel is activated by PKA and ATP, implying a regulated
barrier between positions 95 and 98. However, we found all
four positions appear to be only accessible to internal MTS
probes in the open state.
Notably, these discrepancies are not limited to data on
TM1, numerous differences between our results on TM6
and 12 (12,16) and those reports by the same group
(18,22) were observed. Though the exact reasons behind
these discrepancies are unknown to us for the time being,
here we discuss several technical differences in experi-
mental design and data presentation. First, whenever
possible, we presented real-time recordings of our data
that offer our readers a direct view of the time course of
current responses to the applied reagents. This kind of
detailed, long-lasting current recording also allows our
readers to more readily discern any unusual changes of
the recorded current as well as the baseline leakage current.
Second, a fast solution change system used in our
Roles of TM1 in CFTR Function 793experiments is essential for accurately assessing the reaction
rate of the introduced thiols to MTS reagents as the solution
change itself does not impose a rate-limiting step. Third,
to determine the state-dependency of those reactive cyste-
ines to MTSES, we adopted a method similar to that de-
signed by Yellen’s lab (46). In contrast, Linsdell’s group
routinely used the preincubation method (see (35) for
details), which negated any opportunity to monitor either
the time course or the extent of the reaction, or to test its
reversibility, leaving some room for undesirable effects.
Finally, different expression systems were used (baby
hamster kidney cells in Linsdell’s group versus Chinese
hamster ovary cells in our study).Cysteine scanning on TM1 confirms a bottleneck
region in the CFTR pore
Previous studies have come to a general consensus that the
whole ion permeation pathway of CFTR consists of an inner
vestibule and an outer vestibule flanking a rate-limiting
region (42,48,49). SCAM experiments using channel imper-
meant MTS reagents have specified the relative locations of
each of these components in TM6 (15,16). By identifying
the accessibility limits of intracellularly and extracellularly
applied MTS reagents, one can safely conclude that residues
338–341 in TM6 constitute the bottleneck region of the pore
(15,16). Interestingly, the present studies also pinpoint a
similar 4-amino-acid region (102–106) in TM1 that prevents
MTS reagents from passing through the pore. Because the
residues on either side of this presumed narrow region of
the pore can be readily accessed by the bulky MTS reagents,
it appears that the physical dimensions of both internal
and external vestibules need to be at least 6 A˚ wide. As 4
amino acids are only sufficient to span ~1 helical turn of
an a-helix, if both TM1 and TM6 assume this type of
secondary structure, the CFTR pore indeed looks like an
hourglass (47) with a narrow region of ~5–6 A˚ in length.
Considering the diameter of 3.6 A˚ for a chloride ion, we
reckon that this narrow region can only accommodate one
chloride ion at a time.
Is this bottleneck region CFTR’s anion selectivity filter?
Although alanine substitution experiments with residues in
TM6 do support a role of this region in discriminating
monovalent and divalent anions (50), it is questionable if
a well-defined selectivity filter exists in the CFTR pore
(48). Recent molecular dynamics simulations of a CFTR
homology model (23) reveal potential candidates near this
region that may coordinate the chloride ion in the pore
(namely, S341 in TM6, T1134 in TM12, and K95 in
TM1), but the current study suggests that K95 may be posi-
tioned too far to make significant contributions to the role of
this presumed bottleneck for chloride permeation. It is none-
theless interesting to note that although CFTR is an anion
channel, positively charged MTSET, just like negatively
charged MTSES, can reach position 102 from the cyto-plasmic side as well as position 106 from the external side
of the channel (see Fig. S6). Thus, neither internal nor
external vestibule seems to impose a strict anion-over-cation
selectivity. Nevertheless, many positively charged amino
acids scattered in TM1, TM5, and TM6 have been proposed
to serve to concentrate chloride ions in both internal and
external vestibules (47,49,51). One needs to caution that
the existence of positively charged amino acids in the
pore-forming segments does not guarantee that the side
chains of these amino acids actually protrude into the ion
permeation pathway. R347 in TM6 is a good example.
Although early work suggests a pivotal role this residue
plays in chloride binding in the pore (52), subsequent
studies indicate otherwise (16,22,53). For TM1, R104 has
been implicated in assuming a similar role in chloride selec-
tivity (47), but this work did not find corroborating
evidence.A revised topology for TM1
Hydropathy analysis has been the method of choice for as-
signing membrane spanning segments of an integral
membrane protein without any prior knowledge about the
structure (54,55). CFTR’s TMD topology was first deter-
mined by such means more than two decades ago (1).
Research based on this topology has provided ample mech-
anistic insights into pore architecture, ion selectivity, and
gating motions. Lately, computational studies of CFTR
based on crystal structures of ABC transporters (23,32–
34) also shed light on the structure/function relationship
of this molecule. However, although a gross picture of
CFTR’s TMDs seems consistent in different CFTR models,
detailed structures of each TM could differ considerably
(23,32). We thus chose the original TM1 topology as our
starting point.
Our experimental results show that cysteines introduced
at three positions external to L102, the outermost residue
in traditional TM1, can be modified by extracellularly
applied MTS reagents (Fig. 3 C). These data, together
with the observation that titrating the cysteine introduced
at position 107 can affect ion permeation (Fig. 5 and
Fig. S1), support the idea that residues 103–109 form part
of the external pore. We thus propose a revised topology
for TM1: two helical turns formed by residues 103 to 109
are part of the more structured ion permeation pathway.
The idea that this segment constitutes part of the pore
predicts that mutations of some of these residues may alter
ion permeation. Fig. 7 indeed shows that cysteine substitu-
tion at several of these positions decreases the single-
channel amplitude. (Previous results on TM6 are presented
for comparison.) It is noted that those positions of which
mutations alter the single-channel conductance include not
only the aforementioned bottleneck region, but also areas
flanking this segment. Interestingly, if we align TM1 and
TM6 using the outermost position whose mutation affectsBiophysical Journal 104(4) 786–797
FIGURE 7 Effects of cysteine substitution on the single-channel current
amplitude. (A) Representative single-channel traces for WT/Cysless, A96C/
Cysless, I106C/Cysless, and P99C mutant channels. (B and C) Summary of
single-channel current amplitudes for WT/Cysless and all cysteine-
substituted mutant channels in TM1 (B) or TM6 (C). Single star specifies
no channel activity was detected for G103C. The daggers indicate that
the single channel current amplitude is too small or too variable to be
measured accurately. Double stars indicate positions where cysteine substi-
tution alters the single channel current amplitude significantly (p < 0.05,
student’s t-test). Data were acquired from 3 to 4 patches for each mutant.
Results on TM6 were obtained from Bai et al. (16).
794 Gao et al.the single-channel amplitude as the extracellular end for
each TM (Y109 in TM1 and R334 in TM6), we also
successfully align the intracellular accessibility limits (i.e.,
L102 in TM1 and S341 in TM6) as well as the extracellular
accessibility limit (i.e., I106 in TM1 and T338 in TM6).
After this adjustment, L102 will be located close to the
middle of the newly defined TM1 (cf. (35)). It follows that
the three other positive hits (C92, C95, and C98) will reside
within three helical turns down from L102. Incidentally,
since S341 and M1140 are the internal accessibility limit
for TM6 and TM12, respectively, the other positive hits in
these two TMs are also vested within 3–4 helical turns
from the referenced positions. On the basis of this revised
TM1, we reason that residues internal to E92 may not be
important for ion permeation, a conjecture consistent with
the observations that cysteines introduced into these posi-
tions are not reactive to MTSES (Fig. 2) or reactive to
MTSES but without any effects on chloride permeation,
and that almost none of the cysteine substitutions at these
positions significantly affects the single-channel amplitude
(Fig. 7). Of note, a different alignment between TM1 andBiophysical Journal 104(4) 786–797TM6 was deduced based on cross-linking experiments for
paired cysteines introduced into these two TMs (35).Possible gating motions of TM1 revealed by state-
dependent modifications and crystal structures
of ABC exporters
Our previous work on TM6 and TM12 provides data sup-
porting the hypothesis that CFTR evolves from a primordial
ABC exporter by degenerating its cytoplasmic gate ((12),
but cf. (13)). Specifically, we showed that cysteines placed
at positions 344, 348 in TM6 and 1141, 1148 in TM12
can react readily with cytoplasmic Texas Red MTSEA
(~13 A˚ wide for its headgroup) even when the channel is
closed. We were therefore surprised to observe negligible
modification of cysteines introduced at positions 95, 98,
and 102 in the absence of ATP. Although we were not
able to measure the modification rate for E92C because of
poor expression, in five patches yielding microscopic
current, MTSES appears to modify the introduced cysteine
when the channel is opened (see Fig. S7). Thus, all four
positive hits for cytoplasmic application of MTSES exhibit
strict state dependency (cf. (35)).
Many of the data presented in our previous SCAM studies
on TM6 and TM12 are consistent with a helix rotational
movement during CFTR’s gating cycle (12,16). However,
this scenario is unlikely applicable to TM1 because those
four reactive positions are aligned on one face of the helix
but none of the neighboring positions are reactive. We there-
fore reasoned that at least the intracellular half of TM1 may
undergo conformational rearrangements between lining the
pore in the open state and hiding behind other parts of the
protein in the closed state.
As the crystal structure of CFTR is not yet available, we
decided to resort to homology models built on the template
of CFTR’s close cousin, ABC exporters, to gain some
insights into this unique state-dependency of introduced
cysteines in the cytoplasmic side of TM1. Several such
models of CFTR have been published in recent years
(23,32,34). We first examined the homology model of
CFTR in the presumed open conformation based on the
crystal structure of the outward-facing configuration of
Sav1866. The modeled structure clearly shows that TM1,
TM6, and TM12 line the open pore (Fig. 8 A) (32). On
the other hand, if we accept the premise that the inward-
facing structures of ABC exporters may share some resem-
blances with the closed state of CFTR, they may shed some
light on the plausible orientation of TM1 in the closed
conformation of CFTR. We then examined the homology
model based on the inward-facing configuration of MsbA
(34). Interestingly, TM1 now moves to a position where
its contribution to pore-lining is extremely limited (Fig. S8).
As the resolution of the inward-facing structure of MsbA
is not ideal, we also turned to the crystal structure of
recently solved TM287-TM288 in an inward-facing
FIGURE 8 Relative orientations of TM1 in a homology model of CFTR
and positions of TM1 in the crystal structure of an ABC exporter, TM287-
TM288. (A) Surface views of TMDs in the homology model of CFTR based
on the outward configuration of Sav1866 (32). Domains and segments were
presented in different colors as indicated. (B) Surface views of the crystal
structure of TM287-TM288 (31) in an inward-facing conformation. Two
NBDs were removed for a better view from the intracellular side. Detailed
cross-section views can be found in Fig. S9. Figures were prepared with
PyMol (V0.99; Schro¨dinger).
Roles of TM1 in CFTR Function 795conformation (31). Fig. 8 B shows that the first transmem-
brane segment of TM287-TM288 is located mainly in the
periphery of the whole structure. Looking into the substrate
translocation pathway from the cytoplasmic side, we see
a very minor contribution of TM1 in the inner contour of
the pore (Fig. 8 B). Similar observations were made with
the crystal structure of the inward-facing configuration of
another ABC exporter, P-glycoprotein (30). If, and we admit
that it is a big if, CFTR and these ABC exporters share
similar conformational changes during the gating/transport
cycle, CFTR’s TM1 does undergo a fairly large-scale rear-
rangement during gating transitions.
Once we accept the possibility that TM1 undergoes major
conformational changes during gating transitions, it is not
surprising to see alterations in gating by the mutation itself
(e.g., L102C), as well as by subsequent chemical modifica-
tions (Fig. 5). It is nevertheless interesting to note that in
L102C/E1371Q-CFTR, the gate can open and close repeat-
edly even when the NBDs are in a dimeric configuration(Fig. S3). On the other hand, modification of L102C by
MTSET literally renders the channel permanently open
even long after ATP is removed and presumably NBDs
have been separated. In other words, what these manipula-
tions reveal is the potential autonomy of CFTR’s gate in
TMDs irrespective of the status of its NBDs, an assertion
echoing a revised gating model featuring an energetic
coupling between CFTR’s NBDs and TMDs (10). In
summary, the data presented in this work support the idea
that contrary to TM6 and TM12, at least the cytoplasmic
half of TM1 contributes to pore-lining only in the open
channel conformation. Because only one face of TM1 helix
lines the ion permeation pathway, suggests that even in the
open state, side chains of the majority of amino acids in
TM1 remain concealed by other parts of the CFTR protein
or membrane lipids. We contend that these structural impli-
cations from our functional studies should be taken into
consideration for future computer modeling of the CFTR
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